Subclassification of chronic rhinosinusitis

Laryngoscope

Volumn 123, Issue SUPPL. 2, 2013, Pages

  Han, Joseph K ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

allergy; and cystic fibrosis; aspirin triad; asthma; inflammation; interleukin; nasal polyp; phenotype; Sinusitis; subclassification

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5;

ADOLESCENT; ADULT; AGED; ALLERGIC FUNGAL SINUSITIS; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; ASTHMATIC SINUSITIS WITH ALLERGY; ASTHMATIC SINUSITIS WITHOUT ALLERGY; CASE CONTROL STUDY; CHILD; CHRONIC RHINOSINUSITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE CLASSIFICATION; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MAST CELL; NONASTHMATIC SINUSITIS WITH ALLERGY; NOSE POLYP; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE INDEX; SCHOOL CHILD; SINUSITIS;

ASTHMA; CASE-CONTROL STUDIES; CHRONIC DISEASE; ENDOSCOPY; HUMANS; NASAL POLYPS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS; SINUSITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84874429965     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23979     Document Type: Article

References (32)

1. Chester AC, Antisdel JL, Sindwani R,. Symptom specific outcomes of endoscopic sinus surgery: a systemic review. Otolaryngol Head Neck Surg 2009; 140: 633-639.
2. Ebbens, FA, Georgala C, Luiten S, et al. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope 2009; 119: 401-408.
3. Wallwork B, Coman W, MacKay-Sim A, et al. A double-blind randomized placebo controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006; 116: 189-193. (Pubitemid 44383921)
4. Haruna, S, Shimada C, Ozawa M, et al. A study of poor responders for long term low dose macrolide for chronic sinusitis. Rhinology 2009; 47: 66-71.
5. Demarcantonio MA, Han JK,. Systemic therapies in managing sinonasal inflammation. Otolaryngol Clin North Am 2010; 43: 551-563.
6. Krouse JH, Brown RW, Fineman SJ, et al. Asthma and the unified airway. Otolaryngol Head Neck Surg 2007; 136 (5 suppl): S75-S106. (Pubitemid 46616971)
7. Caughey RJ, Jameson MJ, Gross CW, et al. Anatomic risk factors for sinus disease: fact or fiction? Am J Rhinol 2005; 19: 334-339. (Pubitemid 41341772)
8. Payne SC, Han JK, Huyett P, et al. Microarray analysis of distinct gene transcription profiles in noneosinophilic chronic sinusitis with nasal polyps. Am J Rhinol 2008; 22: 568-581.
9. Early SB, Hise K, Han JK, et al. Hypoxia stimulates inflammatory and fibrotic responses from nasal polyp derived fibroblasts. Laryngoscope 2007; 117: 511-515. (Pubitemid 46407764)
10. Hekiert AM, Kofonow JM, Doghramji, et al. Biofilms correlate with Th1 inflammation in the sinonasal tissue of patients with chronic rhinosinusitis. Otolaryng Head Neck Surg 2009; 141: 448-453.
11. Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 107: 469-476.
12. Oh CK, Geba GP, Molfino N,. Investigational therapeutics targeting the IL4/IL13/STAT 6 pathway for treatment of asthma. Eur Respir Rev 2000; 19: 46-54.
13. Bachert C, Zhang N, Holtappels G, et al. Presence of IL5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 2010; 126: 962-968.
14. Steinke JW, Payne SC, Tessier ME, et al. Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis. J Allergy Clin Immunol 2009; 124: 1352-1354.
15. Tanaka A, Obashi Y, Kakinoki Y, et al. Immunotherapy suppresses both Th1 and Th2 responses by allergen stimulation, but suppression of the Th2 response is more important mechanism related to the clinical efficacy of immunotherapy for perennial allergic rhinitis. Scand J Immunol 1998; 48: 201-211. (Pubitemid 28366012)
16. Nelson HS,. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 2007; 119: 872-880. (Pubitemid 46527809)
17. Kim BS, Park SM, Uhm TG, et al. Effect of single nucleotide polymorphisms within IL4 promoter on aspirin intolerance in asthmatics and IL4 promoter activity. Pharmacogenet Genomics 2010; 20: 748-758.
18. Higashi N, Taniguchi M, Mita H, et al. Clinical features of asthmatic patients with increase urinary LTE4 excretion; Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2004; 113: 277-283. (Pubitemid 38210550)
19. Szczeklik A, Nizankowska E, Duplaga M,. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000; 16: 432-436.
20. Moebus RG, Han JK,. Immunomodulatory treatments for aspirin sensitivity triad. Am J Rhinol Allergy 2012; 26: 134-140.
21. Ciaferoni A, Schroeder JT, Kim J, et al. Selective inhibition of IL4 gene expression in human T cells by aspirin. Blood 2001; 97: 1742-1749. (Pubitemid 32217242)
22. Rothe T, Achermann R, Hug J, et al. Incomplete aspirin desensitization in an aspirin-sensitive asthmatic. Int Arch Allergy Immunol 1996; 109: 298-300. (Pubitemid 26056209)
23. Bent JP, Kuhn FA,. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1994; 111: 580-588. (Pubitemid 24376646)
24. Upadhyaya B, Yin Y, Hill BJ, et al. Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cell. J Immunol 2011; 187: 3111-3120.
25. Prussin C, Yin Y, Upadhyaya B,. Th2 heterogeneity: does function follow form? J Allergy Clin Immunol 2010; 126: 1094-1098.
26. Foreman A, Psaltis AJ, Tan LW, et al. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy 2009; 23: 556-561.
27. Carpagnano GE, Barnes PJ, Geddes DM, et al. Increased leukotriene B4 and IL6 in exhaled breath condensate in cystic fibrosis. Am J Resp Crit Med 2003; 167: 1109-1112. (Pubitemid 36459657)
28. Valone FH,. Regulation of human leukocyte function by lipoxygenase products of arachidonic acid. Contemp Top Immunobiol 1984; 14: 155-170.
29. Hassan J, Feighery C, Bresnihan B, et al. Serum IgA and IgG subclasses during treatment for acute respiratory exacerbations in cystic fibrosis: analysis of patients colonized with mucoid or nonmucoid strains of Pseudomonas aeruginosa. Immunol Invest 1994; 23: 1-13.
30. Mainz JG, Schiller I, Ritschel C, et al. Sinonasal inhalation of dornase alfa in CF: a double blinded placebo controlled cross over pilot study. Auris Nasus Larynx 2011; 38: 220-227.
31. Morrin M, Reen DJ,. Inhibition of the adherence of Pseudomonas aeruginosa to epithelial cells by IgG subclass antibodies. J Med Microbiol 1993; 39: 459-466. (Pubitemid 24007779)
32. Becker SS, de Alarcon A, Bomeli SR, et al. Risk factors for recurrent sinus surgery in cystic fibrosis: review of a decade of experience. Am J Rhinol 2007; 21: 478-482. (Pubitemid 47360037)